Voltar
Artigo Produção Nacional Revisado por pares
BIBTEX RIS

Amphotericin B lipid complex in the treatment of severe paracoccidioidomycosis: a case series

2016; Elsevier BV; Volume: 48; Issue: 4 Linguagem: Inglês

10.1016/j.ijantimicag.2016.06.011

ISSN

1872-7913

Autores

Paulo Mendes Peçanha, Stella de Souza, Aloísio Falqueto, Tânia Regina Grão-Veloso, Ludmila Ventura Lírio, Carlos Urbano Gonçalves Ferreira, Aline Rocha Santos, Hélbia Garcia Costa, Lúcia Renata Meirelles de Souza, Felipe Francisco Tuon,

Tópico(s)

Nail Diseases and Treatments

Resumo

Amphotericin B deoxycholate is the main option for intravenous (i.v.) treatment of severe paracoccidioidomycosis (PCM). This is the first report of amphotericin B lipid complex (ABLC) in the treatment of PCM. Among 28 patients, cure was achieved in all patients (100%) using ABLC. Mean and median daily doses of ABLC were 3.39 mg/kg/day and 3.35 mg/kg/day, respectively. ABLC may be a choice in the treatment of severe forms of PCM or when i.v. options are required.

Referência(s)